The chemical compositions of multiple or recurrent stones, of which the central areas were analyzed by infrared spectroscopy, were compared in each of 110 cases afflicted with upper urinary tract calculi of every type. Nearly all central areas of multiple stones or of initial and recurrent stones in each individual were qualitatively shown to have the same chemical composition except for only 8 cases. Sixty-seven of these one hundred and ten cases had multiple or recurrent stones composed of mixed calcium oxalate-calcium phosphate, and these stones were also used in the measurement of the mixture ratio of phosphate/oxalate from previously formulated infrared spectrum charts. The fairly similar ratios were found in most multiple stones. In the recurrent stones, however, the decreasing ratios were demonstrated in cases with initial stones in the kidney, whereas the increasing ratios in all cases with initial stones in the opposite ureters, and in more than half of the cases with initial stones in the ipsilateral ureters.

Keywords:
Chemical composition of uroliths, Stones, multiple, Stones, recurrent
This content is only available via PDF.
© 1989 S. Karger AG, Basel
1989
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.